CMS opens coverage analysis on oxygen for cluster headaches
This article was originally published in The Gray Sheet
Executive SummaryAt the request of the American Headache Society and the American Academy of Neurology, CMS opened a national coverage analysis April 9 on home use of oxygen to treat cluster headaches. Current durable medical equipment policy on home oxygen does not address its use to treat cluster headaches, which CMS says may impact as many as 36,000 Medicare beneficiaries. According to the agency, cluster headaches may occur over many weeks, and are characterized by severe stabbing pain behind the eye, often accompanied by redness and tearing of the eye, as well as nasal congestion. Comments are due May 9
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.